Clinical Trial Update: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated flavopiridol in patients with chronic lymphocytic leukemia and prolymphocytic leukemia; the study was terminated and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-10-24